IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding IN8BIO, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 1.21M | 1.37M | +157.7K (+13.0%) |
| Value | $2.79M | $1.78M | −$1.02M (−36.4%) |
New holders (1)
Institutions that held IN8BIO, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royal Bank of Canada | 46 | $0 | 0.00% |
Sold out (0)
Institutions that held IN8BIO, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
None.